10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0000950123-19-000828`
Period End Date	20181231
Filing Date	20190207
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	arwr-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 33 Cash Flow Statement 50 Stockholders Equity 12

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.51M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	92.59M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$189.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.17M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.51M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$327.38K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	92.59M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.55M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.27M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$478.31K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$640.12K	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$53.98M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$46.40M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$248.95M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$78.77M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.92M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.94M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$18.76M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$18.34M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$59.60M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$111.61M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$340.95M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.94M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.04M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.91M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.63M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$307.33K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$212.16K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$600.00	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$124.93M	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$223.82K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$12.36M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$134.61M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.70M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.66M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$33.17M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.10M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$34.84M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.00M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 92,591,457 and 88,505,302 shares issued and outstanding as of December 31, 2018 and September 30, 2018, respectively	`CommonStockValue`	$184.96K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 92,591,457 and 88,505,302 shares issued and outstanding as of December 31, 2018 and September 30, 2018, respectively	`CommonStockValue`	$180.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$647.14M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$582.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-21.56K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-43.74K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-487.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-475.23M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$95.80M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$172.06M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$111.61M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$340.95M	USD	Point-in-time

Income Statement 33 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.66M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.51M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$17.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$12.92M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.40M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.14M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$17.32M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$23.71M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$10.95M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-13.81M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$163.73K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.09M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$450.74K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.09M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$614.47K	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.20M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$12.04M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$12.04M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-13.20M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.13	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.13	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	74.83M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.09M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	74.83M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.59M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.53K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.18K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-13.21M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$12.02M	USD	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-13.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$12.04M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$450.74K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.72M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.09M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.14M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.18M	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-107.78K	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$156.64K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.84M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$82.13K	USD	1 Quarter
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$29.22K	USD	1 Quarter
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$120.91K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-3.39M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$158.10M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.13M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.63M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.49M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.55M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-265.84K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$43.91K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-14.69M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$168.28M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$135.41K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$737.49K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.02M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$69.27M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.51M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.25M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-67.76M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$1.36M	USD	1 Quarter
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	1 Quarter
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$197.79K	USD	1 Quarter
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$1.00M	USD	1 Quarter
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$224.08K	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$26.29K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$59.11M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$159.64M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.31M	USD	1 Quarter
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$11.53M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$189.77M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$11.53M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$189.77M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Interest Paid	`InterestPaidNet`	$44.72K	USD	1 Quarter
Interest Paid	`InterestPaidNet`	$27.44K	USD	1 Quarter

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.72M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	166,327.00	shares	1 Quarter
Stock issuances	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-9.53K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.18K	USD	1 Quarter
Net income for the three months ended December 31, 2018	`ProfitLoss`	$-13.20M	USD	1 Quarter
Net income for the three months ended December 31, 2018	`ProfitLoss`	$12.04M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.